H.C. Wainwright Reiterates Buy Rating on Compugen (CGEN)

June 4, 2026 6:42 AM

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating and $4.00 price target on Compugen (NASDAQ: CGEN).The analyst commented: "At ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found